Acute Seizure Management Orders
For any actively seizing patient, immediately administer IV lorazepam 4 mg at 2 mg/min (or 0.1 mg/kg in pediatrics, max 2 mg) as first-line treatment, with airway equipment at bedside and continuous vital sign monitoring. 1, 2, 3
Immediate Actions (First 0-5 Minutes)
Initial Assessment & Stabilization:
- Assess circulation, airway, breathing (CAB) and position patient on side in recovery position 1
- Establish IV access immediately 2, 3
- Check fingerstick glucose and correct if <60 mg/dL 1, 2
- Apply continuous cardiac monitoring, pulse oximetry, and blood pressure monitoring 1, 4
- Have airway equipment and bag-valve-mask immediately available at bedside 5
- Administer high-flow oxygen 1
First-Line Anticonvulsant (Benzodiazepines):
- IV lorazepam 4 mg at 2 mg/min (adults) or 0.1 mg/kg (max 2 mg) in pediatrics 1, 2, 3
- May repeat once after 5-10 minutes if seizure continues 2, 3
- Alternative if no IV access: Intramuscular midazolam 10 mg (adults) or 0.2 mg/kg (pediatrics) 1
- Alternative: Intranasal midazolam or buccal midazolam (0.2-0.5 mg/kg) 1, 6
Second-Line Treatment (If Seizures Continue After 10-15 Minutes)
Status epilepticus is defined as seizures lasting >5 minutes and requires immediate escalation to second-line agents. 1, 2
Choose ONE of the following second-line agents (all have similar efficacy 68-88%): 1, 2, 3
Option 1: Fosphenytoin (Traditional Choice)
- Dose: 20 mg PE/kg IV at maximum rate of 50 mg/min (adults) or 1-3 mg/kg/min (pediatrics) 1, 2, 4
- Efficacy: 84% seizure control 2
- Monitoring: Requires continuous ECG and blood pressure monitoring due to 12% hypotension risk and cardiac arrhythmia risk 1, 2, 4
- Infusion requirements: Use 0.22-0.55 micron in-line filter, dilute in normal saline to ≥5 mg/mL concentration 4
Option 2: Valproate (Preferred for Cardiovascular Safety)
- Dose: 20-30 mg/kg IV over 5-20 minutes 1, 2, 3
- Efficacy: 88% seizure control with 0% hypotension risk 2, 3
- Advantage: Less hypotension than fosphenytoin while maintaining similar efficacy 2
Option 3: Levetiracetam (Preferred for Elderly/Cardiac Patients)
- Dose: 30 mg/kg IV (max 2500-3000 mg) over 5-10 minutes 1, 2, 3
- Efficacy: 68-73% seizure control 2, 3
- Advantage: Minimal cardiovascular effects, no cardiac monitoring required 2, 3
Option 4: Phenobarbital
- Dose: 20 mg/kg IV over 10 minutes 1, 2
- Efficacy: 58.2% seizure control 2
- Caution: Higher risk of respiratory depression 2
Third-Line Treatment: Refractory Status Epilepticus (If Seizures Continue After 30-40 Minutes)
Refractory status epilepticus is defined as seizures continuing despite benzodiazepines and one second-line agent. 2, 3
Immediate Actions:
- Transfer to ICU 1, 3
- Initiate continuous EEG monitoring 1, 2, 3
- Prepare for intubation and mechanical ventilation 2, 3
Choose ONE anesthetic agent:
Option 1: Midazolam Infusion (First Choice)
- Loading dose: 0.15-0.20 mg/kg IV 1, 2, 3
- Continuous infusion: Start at 1 mg/kg/min, titrate up by 1 mg/kg/min every 15 minutes to max 5 mg/kg/min 2, 3
- Efficacy: 80% seizure control 2, 3
- Hypotension risk: 30% 2, 3
Option 2: Propofol (For Intubated Patients)
- Loading dose: 2 mg/kg bolus 1, 2, 3
- Continuous infusion: 3-7 mg/kg/hour, titrate to EEG burst suppression 2, 3
- Efficacy: 73% seizure control 2, 3
- Hypotension risk: 42% 2
- Advantage: Shorter ventilation time (4 days vs 14 days with pentobarbital) 2
Option 3: Pentobarbital (Most Effective but Highest Risk)
- Loading dose: 13 mg/kg 2, 3
- Continuous infusion: 2-3 mg/kg/hour 2, 3
- Efficacy: 92% seizure control (highest) 2, 3
- Hypotension risk: 77% (highest) 2
Concurrent Diagnostic Workup
Search for and treat reversible causes simultaneously: 2, 3
- Hypoglycemia (check fingerstick glucose immediately) 1, 2
- Hyponatremia (send basic metabolic panel) 2, 3
- Hypoxia (pulse oximetry, arterial blood gas) 2
- Drug toxicity or withdrawal syndromes (urine drug screen, alcohol level, medication history) 2, 3
- CNS infection (consider lumbar puncture after stabilization) 2, 3
- Ischemic stroke or intracerebral hemorrhage (CT head non-contrast) 2, 3
EMS Activation Criteria
Activate emergency response system for: 1
- First-time seizure 1
- Seizure lasting >5 minutes 1
- Multiple seizures without return to baseline between episodes 1
- Seizure in infant <6 months of age 1
- Seizure in pregnant patient 1
- Seizure with traumatic injury, difficulty breathing, or choking 1
- Seizure occurring in water 1
- Patient does not return to baseline within 5-10 minutes after seizure stops 1
Critical Safety Measures
DO NOT: 1
- Restrain the seizing patient 1
- Place anything in the patient's mouth 1, 5
- Give oral medications, food, or liquids during or immediately after seizure 1, 5
- Use neuromuscular blockers alone (they only mask motor manifestations while allowing continued electrical seizure activity and brain injury) 2
- Skip directly to third-line agents without trying benzodiazepines and a second-line agent first 2
DO: 1
- Stay with the patient continuously 1
- Clear area around patient to prevent injury 1
- Position patient on side in recovery position 1
- Monitor respiratory status continuously and be prepared to provide ventilatory support 1, 2, 3
Maintenance Therapy After Seizure Control
After resolution of status epilepticus, administer maintenance doses: 1
- Lorazepam 0.05 mg/kg (max 1 mg) IV every 8 hours for 3 doses 1
- Levetiracetam 15-30 mg/kg IV every 12 hours 1
- Phenobarbital 1-3 mg/kg IV every 12 hours (if used) 1
- Continue the second-line agent that was effective at appropriate maintenance dosing 3
Special Considerations
Pediatric Dosing Adjustments:
- Lorazepam: 0.05-0.1 mg/kg IV (max 2 mg per dose) 1
- Fosphenytoin: 1-3 mg/kg/min or 50 mg/min, whichever is slower 4
- All second-line agents: Use weight-based dosing as specified above 1
Post-Ictal Period: